NGAL is an early predictive biomarker of contrast-induced nephropathy in children.
Hirsch R, Dent C, Pfriem H, Allen J, Beekman RH 3rd, Ma Q, Dastrala S, Bennett M, Mitsnefes M, Devarajan P.
Hirsch R, et al. Among authors: devarajan p.
Pediatr Nephrol. 2007 Dec;22(12):2089-95. doi: 10.1007/s00467-007-0601-4. Epub 2007 Sep 14.
Pediatr Nephrol. 2007.
PMID: 17874137
Clinical Trial.